News

It’s enough to make one feel old – old enough to remember when Foster’s Group spun off its wine business, in the form of Treasury Wine Estates, in May 2011, only four months before Foster’s itself disappeared from the Australian share market, taken over by Anglo-South African brewer SABMiller, which became AB InBev in 2016….

After finishing up 1.9% for the week, taking the recovery to 20% off the market bottom in March, the S&P/ASX 200 (ASX: XJO) looks to open strongly again today.

In general we are sceptical about capital raisings in Australia, with the ‘private placement’ structure heavily tilted towards investment banks, broking houses (and their clients) and pension funds able to take on outsized allocations.

The S&P/ASX 200 (ASX: XJO) fell on Thursday, taking the US lead to fall 1%, driven primarily by the banking sectors as investors become wary of the need for greater loan provisions.

The S&P/ASX 200 (ASX: XJO) rose on Tuesday and is expected to rise again today following US markets.

Investors who are relying on bank stocks for dividends may need to look elsewhere as new measures mean they are likely to miss out on the equity income.

Australian oil stocks including Woodside Petroleum Ltd (ASX: WPL), Santos Ltd (ASX: STO) and Oil Search Limited (ASX: OSH) will rebound.

In the latest of our never sell stocks, is one of Australia’s true global leaders, CSL, or Commonwealth Serum Laboratories. The company was founded in 1916 and was actually part of the Federal Government at the time. CSL is a biopharmaceutical company that researches, develops, manufactures and markets products to treat and prevent human medical…

The uncertainty in equity markets is prompting listed companies to withdraw their earnings guidance. But analysts are calling on a number of companies who have not provided updates to assist investors by giving a clear outlook. Around 34 per cent of the ASX 100 and 25 per cent of the stocks in the Small Ordinaries…